These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

112 related articles for article (PubMed ID: 2744728)

  • 1. Genetic predisposition to drug hepatotoxicity: role in hepatitis caused by amineptine, a tricyclic antidepressant.
    Larrey D; Berson A; Habersetzer F; Tinel M; Castot A; Babany G; Lettéron P; Freneaux E; Loeper J; Dansette P
    Hepatology; 1989 Aug; 10(2):168-73. PubMed ID: 2744728
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Genetically determined oxidation polymorphism and drug hepatotoxicity. Study of 51 patients.
    Larrey D; Tinel M; Amouyal G; Freneaux E; Berson A; Fouin-Fortunet H; Babany G; Letteron P; Iglicki F; Slama JL
    J Hepatol; 1989 Mar; 8(2):158-64. PubMed ID: 2715619
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Amineptine induced liver injury. Report of two cases and brief review of the literature.
    Lazaros GA; Stavrinos C; Papatheodoridis GV; Delladetsima JK; Toliopoulos A; Tassopoulos NC
    Hepatogastroenterology; 1996; 43(10):1015-9. PubMed ID: 8884331
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Amineptine-induced cholestatic hepatitis. 5 cases (author's transl)].
    Bories P; Pomier-Layrargues G; Chotard JP; Citron D; Capron-Chivrac D; Capron JP; Michel H
    Nouv Presse Med; 1980 Dec; 9(48):3689-92. PubMed ID: 7454584
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cross hepatotoxicity between tricyclic antidepressants.
    Larrey D; Rueff B; Pessayre D; Danan G; Algard M; Geneve J; Benhamou JP
    Gut; 1986 Jun; 27(6):726-7. PubMed ID: 3721296
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Hepatitis caused by amineptine : a case with reintroduction of the drug].
    Cleau D
    Gastroenterol Clin Biol; 1981 Nov; 5(11):1067. PubMed ID: 7308682
    [No Abstract]   [Full Text] [Related]  

  • 7. [Hepatitis caused by amineptine : 2 cases].
    Ramain JP; Labayle D; Buffet C; Chaput JC; Etienne JP
    Gastroenterol Clin Biol; 1981 Apr; 5(4):469-71. PubMed ID: 7227753
    [No Abstract]   [Full Text] [Related]  

  • 8. Amineptine, a tricyclic antidepressant, inhibits the mitochondrial oxidation of fatty acids and produces microvesicular steatosis of the liver in mice.
    Le Dinh T; Freneaux E; Labbe G; Letteron P; Degott C; Geneve J; Berson A; Larrey D; Pessayre D
    J Pharmacol Exp Ther; 1988 Nov; 247(2):745-50. PubMed ID: 3183967
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Hepatic injury associated with amineptine therapy.
    Ricca Rosellini S; Grilli F; Gaudio M; Saragoni A; Miglio F
    Ital J Gastroenterol; 1990 Feb; 22(1):40-3. PubMed ID: 2131927
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Is amineptine hepatotoxic?].
    Bentata-Pessayre M; Krivitzky A; Callard P; Delzant G
    Rev Med Interne; 1981; 2(2):177. PubMed ID: 7256022
    [No Abstract]   [Full Text] [Related]  

  • 11. Hepatic and pancreatic injury associated with amineptine therapy.
    Sebastián Domingo JJ; Simón Marco MA; Uribarrena Echebarría R
    J Clin Gastroenterol; 1994 Mar; 18(2):168-9. PubMed ID: 8189020
    [No Abstract]   [Full Text] [Related]  

  • 12. One more case of hepatic injury due to amineptine.
    Lonardo A; Grisendi A; Mazzone E
    Ital J Gastroenterol Hepatol; 1997 Dec; 29(6):580-1. PubMed ID: 9513840
    [No Abstract]   [Full Text] [Related]  

  • 13. Metabolic activation of the tricyclic antidepressant amineptine--I. Cytochrome P-450-mediated in vitro covalent binding.
    Geneve J; Larrey D; Letteron P; Descatoire V; Tinel M; Amouyal G; Pessayre D
    Biochem Pharmacol; 1987 Feb; 36(3):323-9. PubMed ID: 3814174
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Acneiform eruption caused by amineptine. A case report and review of the literature.
    De Gálvez Aranda MV; Sánchez PS; Alonso Corral MJ; Bosch García RJ; Gallardo MA; Herrera Ceballos E
    J Eur Acad Dermatol Venereol; 2001 Jul; 15(4):337-9. PubMed ID: 11730047
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Amineptine in the management of the depressive syndromes.
    Scarzella L; Scarzella R; Mailland F; Bergamasco B
    Prog Neuropsychopharmacol Biol Psychiatry; 1985; 9(4):429-39. PubMed ID: 4070645
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Pharmacology of amineptine, an antidepressant agent acting on the dopaminergic system: a review.
    Garattini S
    Int Clin Psychopharmacol; 1997 Jul; 12 Suppl 3():S15-9. PubMed ID: 9347388
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Genetic predisposition to drug-induced hepatotoxicity.
    Larrey D; Pageaux GP
    J Hepatol; 1997; 26 Suppl 2():12-21. PubMed ID: 9204405
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Hepatitis, cholestasis and amineptine (author's transl)].
    Bel A; Girard D
    Sem Hop; 1981 Dec 18-25; 57(47-48):1992-6. PubMed ID: 6276980
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Tianeptine--an instance of drug-induced hepatotoxicity predicted by prospective experimental studies.
    Le Bricquir Y; Larrey D; Blanc P; Pageaux GP; Michel H
    J Hepatol; 1994 Nov; 21(5):771-3. PubMed ID: 7890892
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The beneficial effects of amineptine (Survector 100) in the treatment of depression: preliminary results of an Indian multicenter trial.
    Boral GC; Shah LP
    Clin Neuropharmacol; 1989; 12 Suppl 2():S51-7. PubMed ID: 2698271
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.